AI Promises Life-Changing Alzheimer's Drug Breakthrough - (MSN via NewsPoints Desk)

  • Verge Genomics is seeking to use artificial intelligence (AI) to develop new treatments for Alzheimer's disease and other conditions, as reported MSN Monday.

  • "Verge moves drug discovery from the lab to the computer," commented co-founder Alice Zhang, noting that current drug development takes up to 15 years with a price of as much as $2 billion.

  • Zhang developed an algorithm that can search networks of genes in an effort to identify potential treatment targets.

  • Zhang suggested that Verge will have a drug for amyotrophic lateral sclerosis in clinical developoment within five years.

  • "Once we have our first success in a disease, what we do will be very scalable," commented Zhang, continuing "our software platform will be able to discover not one drug but dozens of billion-dollar drugs."

  • A recent Morgan Stanley analysis estimated that digitising drug discovery could cut the cost of drug development by $330 million for each approved drug.

  • FirstWord Reports: Providing insight, analysis and expert opinion on important Pharma trends and challenging issues <Click here>

To read more NewsPoints articles, click here.